Form 4: UL Solutions Director Kevin Kennedy Reports Accrual of Deferred Restricted Stock Unit Dividend Equivalents

Sentiment:

Insider Transaction Report


UL Solutions Inc. Director Kevin Kennedy reported the routine accrual of dividend equivalent rights on his deferred restricted stock units, totaling 14 additional rights, as detailed in a recent SEC Form 4 filing.

Summary

  • Kevin Kennedy, a Director of UL Solutions Inc. (ULS), filed a Form 4 to report changes in his beneficial ownership related to equity compensation.
  • The filing details the accrual of dividend equivalent rights on his deferred restricted stock units (DRSUs) on June 9, 2025.
  • Kennedy acquired 9 dividend equivalent rights related to DRSUs that vested on May 1, 2025; these rights are economically equivalent to one share of Class A Common Stock each.
  • Additionally, he acquired 5 dividend equivalent rights related to DRSUs that will vest on the earlier of May 20, 2026, or the annual meeting date.
  • These dividend equivalent rights are expected to be settled in shares of UL Solutions' Class A Common Stock according to the company's Non-Employee Director Deferred Compensation Plan.
  • Following these transactions, Kennedy's total beneficial ownership of deferred restricted stock units and accrued dividend equivalent rights stands at 4,936 for the first set and 2,792 for the second set.

Sentiment

Score: 6

Explanation: The document is a routine Form 4 filing reporting the accrual of dividend equivalent rights as part of director compensation. It is neutral in terms of company performance but reflects standard corporate governance and compensation practices, which is mildly positive for stability and alignment of interests.

Positives

  • The accrual of dividend equivalent rights indicates ongoing value creation for existing equity awards held by the director.
  • The mechanism for these accruals (dividend equivalent rights) aligns the director's interests with shareholder returns, as they are tied to the company's Class A Common Stock.

Risks

  • The ultimate value of the deferred restricted stock units and their dividend equivalent rights is subject to the future performance and stock price of UL Solutions Inc.
  • Settlement in shares means the actual value received by the director will depend on the Class A Common Stock price at the time of settlement, introducing market price risk.

Future Outlook

The dividend equivalent rights are expected to be settled in shares of UL Solutions' Class A Common Stock either on a date selected by the reporting person under the Non-Employee Director Deferred Compensation Plan or as otherwise provided by the Plan. A portion of the underlying deferred restricted stock units will vest by May 20, 2026, or earlier if the annual meeting occurs before this date.

Management Comments

  • "Each dividend equivalent right is the economic equivalent of one share of the Issuer's Class A Common Stock."
  • "Represents accrual of dividend equivalent rights on deferred restricted stock units held by the Reporting Person."
  • "The dividend equivalent rights have historically been reported as a separate security on Table II, but have been aggregated with the underlying deferred restricted stock units in this Form 4 and will continue to be reported together with the underlying equity award in the future."
  • "The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate."
  • "The deferred restricted stock units vested on May 1, 2025 and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the 'Plan'), or (ii) as otherwise provided by the Plan."
  • "The deferred restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan."

Industry Context

This Form 4 filing is a routine disclosure of insider equity compensation, common across publicly traded companies. The accrual of dividend equivalent rights on deferred restricted stock units is a standard mechanism used to align the interests of non-employee directors with those of shareholders, reflecting a common corporate governance practice in the broader market.

Comparison to Industry Standards

  • The use of deferred restricted stock units (DRSUs) and dividend equivalent rights (DERs) for non-employee director compensation is a common practice among S&P 500 companies, including peers in the business services and testing, inspection, and certification (TIC) sectors like Intertek Group plc or SGS SA, which often utilize similar equity-based incentives to retain and motivate directors while aligning their interests with long-term shareholder value.
  • The vesting schedules and settlement mechanisms, such as settlement upon director's election or plan provisions, are typical for deferred compensation plans for independent directors, ensuring that compensation is tied to continued service and company performance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Policy ClarificationThe filing clarifies that dividend equivalent rights, previously reported separately, will now be aggregated with the underlying deferred restricted stock units in future Form 4 filings, streamlining reporting.06/09/2025Improves clarity and consistency in insider ownership reporting for equity awards.

Stakeholder Impact

  • Shareholders: The accrual of dividend equivalent rights aligns director interests with shareholder returns, as these rights are tied to the company's Class A Common Stock.
  • Directors: Kevin Kennedy's compensation includes these equity-based awards, which vest over time, providing long-term incentives and linking his compensation to company performance.

Next Steps

  • Settlement of the accrued dividend equivalent rights and underlying deferred restricted stock units in Class A Common Stock, as per the Non-Employee Director Deferred Compensation Plan.
  • Future vesting of a portion of the deferred restricted stock units by May 20, 2026, or the annual meeting date.

Key Dates

DateDescription
2025-05-01Vesting date for a portion of the deferred restricted stock units related to the first reported accrual of dividend equivalent rights.
2025-06-09Date of earliest transaction, representing the accrual of dividend equivalent rights on deferred restricted stock units.
2025-06-11Date the Form 4 was signed by the attorney-in-fact.
2026-05-20Latest vesting date for a portion of the deferred restricted stock units related to the second reported accrual of dividend equivalent rights, or earlier if the annual meeting occurs before this date.

Recommendation

hold

Keywords

UL Solutions, ULS, Form 4, SEC filing, beneficial ownership, director compensation, restricted stock units, dividend equivalent rights, equity compensation, insider transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.